【24h】

Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: An alternate model of care

机译:南非农村耐多药结核病和艾滋病的综合家庭治疗:替代治疗模式

获取原文
获取原文并翻译 | 示例
           

摘要

SETTING: Treatment outcomes for multidrug-resistant tuberculosis (MDR-TB) in South Africa have suffered as centralized, in-patient treatment programs struggle to cope with rising prevalence and human immunodeficiency virus (HIV) co-infection rates. A new treatment model is needed to expand treatment capacity and improve MDR-TB and HIV outcomes. OBJECTIVE: To describe the design and preliminary results of an integrated, home-based MDR-TB-HIV treatment program created in rural KwaZulu-Natal. METHOD: In 2008, a decentralized center was established to provide out-patient MDR-TB and HIV treatment. Nurses, community health workers and family supporters have been trained to administer injections, provide adherence support and monitor adverse reactions in patients' homes. Physicians assess clinical response, adherence and the severity of adverse reactions to MDR-TB and HIV treatment at monthly follow-up visits. Treatment outcomes are assessed by monthly cultures and CD4 and viral load every 6 months. RESULTS: Of 80 patients initiating MDR-TB treatment from February 2008 to April 2010, 66 were HIV-coi nfected. Retention has been high (only 5% defaults, 93% of visits attended), and preliminary outcomes have been favorable (77% cured/still on treatment, 82% undetectable viral load). Few patients have required escalation of care (9%), had severe adverse events (8%) or died (6%). CONCLUSION: Integrated, home-based treatment for MDR-TB and HIV is a promising treatment model to expand capacity and achieve improved outcomes in rural, resource-poor and high HIV prevalent settings.
机译:地点:南非的多药耐药性结核病(MDR-TB)的治疗结果受到影响,因为集中式住院治疗方案难以应对患病率上升和人类免疫缺陷病毒(HIV)合并感染率的问题。需要一种新的治疗模式来扩大治疗能力并改善耐多药结核病和艾滋病毒的结局。目的:描述在夸祖鲁-纳塔尔省农村建立的综合性家庭MDR-TB-HIV综合治疗方案的设计和初步结果。方法:2008年,建立了一个分散中心,提供门诊耐多药结核病和艾滋病毒治疗。护士,社区卫生工作者和家庭支持者已接受过培训,可以注射,提供依从性支持并监视患者家中的不良反应。医师在每月的随访中评估对MDR-TB和HIV治疗的临床反应,依从性和不良反应的严重性。通过每月培养一次,每6个月CD4和病毒载量评估治疗结果。结果:在2008年2月至2010年4月开始进行耐多药结核病治疗的80名患者中,有66名被HIV感染。保留率很高(只有5%的违约率,占93%的就诊率),初步结果良好(77%治愈/仍在治疗,82%不可检测的病毒载量)。很少有患者需要升级治疗(9%),发生严重不良事件(8%)或死亡(6%)。结论:耐多药结核病和艾滋病毒的家庭综合治疗是一种有前途的治疗模式,可在农村,资源贫乏和艾滋病毒高发地区扩大能力并取得更好的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号